Posts by: Joana Carvalho

News

uBiome launched a research collaboration program with clinicians from the University of Louisville in Kentucky to investigate the usefulness of the gut microbiome to predict the clinical response of ... Read more

February 18, 2019February 18, 2019

Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows

News

AbbVie‘s Humira (adalimumab) reduces early tissue inflammation, rectal bleeding, and stool frequency in patients with ulcerative colitis, according to a post-hoc analysis of two Phase 3 trials. Findings were published ... Read more

February 6, 2019February 6, 2019

Remote Monitoring Offers Little Benefit to IBD Patients, Study Finds

News

Telemedicine monitoring failed to increase inflammatory bowel disease patients’ confidence or motivation to manage their status, compared to standard routine care, a study reported. The study, “Effect of TELEmedicine for Inflammatory ... Read more

January 30, 2019January 30, 2019

Diet and Clear-Mindedness Most Affected Psychosocial Needs in IBD Patients, Study Reports

News

Among 10 different psychosocial needs, diet and a lack of clear-mindedness were the ones most patients with inflammatory bowel disease felt were affected by their disease, a study reports. The ... Read more

December 5, 2018December 5, 2018

Potential IBD Therapy PTG-200 Safe, Well-tolerated in Healthy Volunteers, Phase 1 Results Show

News

PTG-200, being developed by Protagonist Therapeutics in collaboration with Janssen Biotech for the treatment of moderate and severe Crohn’s disease, was found safe and well-tolerated in healthy volunteers, according to top-line results ... Read more

Posts by: Joana Carvalho

Joana Carvalho

Program to Examine Gut Microbiota’s Role in Predicting Response to Therapies

Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows

Remote Monitoring Offers Little Benefit to IBD Patients, Study Finds

Diet and Clear-Mindedness Most Affected Psychosocial Needs in IBD Patients, Study Reports

Potential IBD Therapy PTG-200 Safe, Well-tolerated in Healthy Volunteers, Phase 1 Results Show

Pin It on Pinterest